Ledger.Open graph →

SEC Form D · filed July 2, 2025

SYNTIS BIO, INC

Offering

$26.5M

Sold

$25.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Teymour Boutros-Ghali · Boston, MADirector Carlo Giovanni Traverso · Boston, MADirector Robert Langer · Boston, MADirector Martin Madaus · Boston, MADirector Rahul Dhanda · Boston, MAExec · Director Chenny Zhang · Boston, MADirector Robert Langer · Boston, MADirector Teymour Boutros-Ghali · Boston, MADirector Rahul Dhanda · Boston, MAExec · Director Carlo Giovanni Traverso · Boston, MADirector Martin Madaus · Boston, MADirector Michael Nannizzi · New York, NYDirector Alfred Lin · New York, NYDirector Alison Brown · Salt Lake City, UTExec · Director Brad Holden · San Francisco, CADirector Mehul Shah · San Jose, CADirector Paul Sigfusson · Tampa, FLDirector Chenny Zhang · Boston, MADirector Michael Nannizzi · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗